• GSK621: AMPK Agonist Workflows for AML and Immunometabolic R

  2026-05-20

  GSK621 enables precise AMPK activation, unlocking robust metabolic and immunometabolic assay workflows in acute myeloid leukemia and tumor microenvironment research. Its superior potency and reproducibility offer clear advantages for apoptosis and autophagy studies. Learn protocol refinements and troubleshooting strategies that maximize GSK621’s impact, as informed by the latest immunometabolic findings.

• Caspase-8 Fluorometric Assay Kit: Innovations in Apoptosis a

  2026-05-20

  Explore the Caspase-8 Fluorometric Assay Kit for advanced cysteine-dependent aspartate-directed protease detection. This in-depth guide reveals new mechanistic insights and experimental protocols for apoptosis and pyroptosis studies.

• Balanced Self-Renewal and Differentiation in Human Intestina

  2026-05-19

  This study introduces a tunable human intestinal organoid system that achieves a controlled balance between stem cell self-renewal and differentiation using a combination of small molecule pathway modulators. The approach enhances cellular diversity and proliferative capacity within a single culture condition, addressing longstanding limitations in organoid modeling for developmental and disease research.

• APEX2’s Role in TERT Expression and Telomerase Regulation in

  2026-05-19

  This study uncovers a novel role for APEX2 in regulating efficient TERT gene expression in human embryonic stem cells, revealing mechanistic links between DNA repair and telomerase activity. The findings deepen our understanding of stem cell maintenance and highlight new avenues for therapeutic modulation in aging and cancer.

• Ibrexafungerp (MK 3118): Applied Workflows for Antifungal In

  2026-05-18

  Ibrexafungerp (MK 3118) introduces a new era of antifungal research, uniquely targeting resistant Candida with oral dosing and limited cross-resistance. Discover how this triterpenoid empowers translational and experimental workflows, especially in tackling echinocandin-resistant infections.

• Clozapine in Schizophrenia Research: Mechanisms and Experime

  2026-05-18

  Explore the multifaceted role of Clozapine, an atypical antipsychotic medication, in schizophrenia research. This article offers a mechanistic deep dive and protocol guidance, revealing how ERK1/2 signaling and receptor specificity inform innovative experimental strategies.

• EV-Transferred ACLY Drives TAM-Mediated Immune Suppression i

  2026-05-17

  The reference study reveals that hepatocellular carcinoma (HCC) cells secrete extracellular vesicles containing ATP-citrate lyase (ACLY), which are taken up by monocytes and drive their differentiation into immunosuppressive tumor-associated macrophages (TAMs). This work identifies a novel, EV-mediated metabolic mechanism for immune suppression in HCC, highlighting new therapeutic strategies targeting TAMs.

• C. albicans EVs Suppress Hyphal Growth via NRG1 Upregulation

  2026-05-16

  This study reveals a novel self-regulatory mechanism by which high concentrations of Candida albicans extracellular vesicles (EVs) inhibit hyphal development through upregulation of the NRG1 transcription repressor. The findings clarify how EV cargo proteins modulate fungal pathogenicity, suggesting new avenues for antifungal strategies and providing a detailed framework for molecular investigation of EV-mediated signaling.

• JSH-23 (SKU B1645): Reliable NF-κB Inhibitor for Inflammatio

  2026-05-15

  This article examines how JSH-23 (SKU B1645) addresses real laboratory challenges in NF-κB signaling pathway studies and inflammation research. By presenting scenario-driven Q&A blocks rooted in published data and workflow realities, we demonstrate how JSH-23 delivers reproducible, data-backed results and practical advantages for biomedical researchers.

• EdU Imaging Kits (488): Reliable S-Phase DNA Synthesis Detec

  2026-05-15

  This article addresses practical challenges in cell proliferation and cytotoxicity assays, illustrating how EdU Imaging Kits (488) (SKU K1175) from APExBIO provide reproducible, sensitive solutions for S-phase DNA synthesis measurement. Scenario-driven Q&A offers evidence-based guidance for biomedical researchers optimizing fluorescence microscopy workflows.

• PD98059 in Redox Biology: MEK Inhibition and Mitochondrial A

  2026-05-14

  Explore how PD98059, a selective MEK inhibitor, uniquely shapes redox signaling, apoptosis, and neuroprotection. This in-depth analysis integrates mechanistic insights and practical guidance for advanced research in cell cycle control and chemoprotection.

• APEX2 Is Essential for TERT Expression in Human Stem Cells

  2026-05-14

  This study establishes APEX2, but not APEX1, as a key regulator of TERT gene expression and telomerase activity in human embryonic stem cells. By highlighting the role of APEX2 at repetitive DNA elements within TERT, the findings illuminate a previously unrecognized axis linking DNA repair enzymes, telomerase regulation, and stem cell biology.

• Pomalidomide (CC-4047) Workflows in Hematological Malignancy

  2026-05-13

  Pomalidomide (CC-4047) enables advanced modulation of the tumor microenvironment and precise interrogation of drug resistance mechanisms in multiple myeloma and related hematological malignancies. This guide delivers stepwise protocol optimizations, troubleshooting strategies, and translational insights grounded in recent mutational landscape findings.

• Oleanolic Acid and Inducible Nitric Oxide Synthase Induction

  2026-05-13

  Harness oleanolic acid’s unique inducible nitric oxide synthase induction for high-efficiency dual-loaded liposome workflows. This guide translates recent breakthroughs in encapsulation efficiency and troubleshooting, empowering antiviral and immune pathway research with proven, universally applicable methodologies.

• Olaparib (AZD2281, Ku-0059436): Reliable PARP Inhibition in

  2026-05-12

  This article addresses real-world laboratory challenges in DNA damage response assays, cytotoxicity screens, and tumor radiosensitization studies using Olaparib (AZD2281, Ku-0059436) (SKU A4154). Through scenario-driven Q&A, we highlight how APExBIO's formulation provides reproducibility, sensitivity, and validated workflow compatibility for BRCA-associated cancer targeted therapy.

16547 records 1/1104 page Next 12345 下5页 Last page